SAVA

SAVA is a biotech company in London, United Kingdom, founded in 2016. It has 2 recorded funding rounds, most recently a Series A in July 2025.

A New Paradigm in Health Monitoring

Headquarters
London
Employees
11–50
Founded
2016
Business Model
B2C
Last Round
Series AJul 2025
Rounds
2

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

SAVA is developing the world's most advanced wearable biosensor, capable of measuring multiple biomarkers — including glucose, lactate, cortisol, and ketones — continuously and in real-time just below the skin. Founded by Imperial College London bioengineers, the company targets chronic condition management and preventative health through seamless, minimally invasive monitoring technology paired with a connected mobile platform.

Summary

It lists 11–50 employees. Its most recent funding was a Series A round in Jul 2025.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJul 2025

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SAVA on Indexed.vc
<a href="https://indexed.vc/companies/sava"><img src="https://indexed.vc/api/badge/company/sava" alt="SAVA on Indexed.vc" width="260" height="76" /></a>